About HEC                                
                            
              
                            
              High-tech light
              
                        
              
                    
              
                
              
            
              
        
              
    
              
    
              

              
    
              
        
              
            
              
                
              
                    
                    
              
                        
              
                            
              
                                
                                    About HEC                                
                            
              
                            
              High-tech light
              
                        
              
                    
              
                
              
            
              
        
              
    
              
    
              



              



              


              
    
              
        
              
            
              
                Development Path            
              
        
              
    
              

              

              
    
              
        
              
            
              
                                
              
                    
              
                        
              
                            
              
                                2023                            
              
                        
              
                        
              
                            
              
                                
              · HEC, an A-share listed company (600673.SH), Zunyi Municipal Government and GAC Group reached a strategic cooperation to improve the layout of the new energy industry
              · HEC Pharm R&D Center was restructured and renamed Sunshine Lake Pharma Co., Ltd. ("HEC Pharma")
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2022                            
              
                        
              
                        
              
                            
              
                                
              ·The construction of Zhejiang Dongyang base was started, with a total investment of 20 billion yuan
              ·Low-carbon high-end battery aluminum foil project started construction in Yichang, Hubei
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2021                            
              
                        
              
                        
              
                            
              
                                
              ·HEC Pharmaceutical Research Institute completed A round of financing of nearly 7 billion yuan
              ·HEC Pharmaceutical Research Institute completed the equity control of  HEC Changjiang Pharmaceutical (01558.HK), realizing the integration of pharmaceutical assets
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2020                            
              
                        
              
                        
              
                            
              
                                
              
    ·Mr. Zhang Yushuai took over as chairman of HEC Group and established a new board of directors of HEC Group. HEC officially entered the 2.0 new era of "co-creation, co-responsibility and sharing"
              ·HEC's first Class 1.1 original innovative drug "Emitasvir Phosphate" was approved for marketing

                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2019                            
              
                        
              
                        
              
                            
              
                                The annual sales of anti-influenza drug Kewei reached nearly 7 billion yuan, setting a new high for similar anti-influenza drug products in China                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2018                            
              
                        
              
                        
              
                            
              
                                
              ·Cordyceps sinensis (breeding product) was included in "Guangdong Province Local Medicinal Materials Standard" (Volume 3)
              ·"Research on key technologies of Cordyceps sinensis breeding and its industrial application" won the first prize of Guangdong Science and Technology Progress Award
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2017                            
              
                        
              
                        
              
                            
              
                                The construction of the Ulanchap base in Inner Mongolia started with an investment of nearly 2 billion yuan                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2016                            
              
                        
              
                        
              
                            
              
                                HEC Health Research Institute was approved by the State Administration of Traditional Chinese Medicine to establish the "Key Research Laboratory of Cordyceps Sinensis Breeding and Product Research and Development"                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2015                            
              
                        
              
                        
              
                            
              
                                
              ·HEC Changjiang Pharmaceutical was listed on the main board of Hong Kong, stock code: 01558.HK 
              ·HEC Pharmaceutical Research Institute is approved by the Ministry of Science and Technology of the People's Republic of China to establish a "State Key Laboratory of New Anti-infective Drug Research and Development"
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2014                            
              
                        
              
                        
              
                            
              
                                The construction of the Nyingchi base in Tibet began, which is a supporting base for the ecological breeding of Cordyceps sinensis                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2013                            
              
                        
              
                        
              
                            
              
                                A-share listed company HEC (600673.SH) issued additional private placements to expand the medium and high pressure formed foil project and the high specific volume corrosion foil project                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2012                            
              
                        
              
                        
              
                            
              
                                Took the lead in realizing the industrialization of Cordyceps sinensis ecological breeding in the world                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2011                            
              
                        
              
                        
              
                            
              
                                HEC's first generic drug approved by the U.S. FDA, Zidovudine Tablets for the treatment of AIDS, was on the market                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2010                            
              
                        
              
                        
              
                            
              
                                Shaoguan started the construction of pharmaceutical industry projects
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2009                            
              
                        
              
                        
              
                            
              
                                Provided oseltamivir phosphate reserve drug for the country's prevention and control of influenza epidemic, and  commended by the National Development and Reform Commission                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2008                            
              
                        
              
                        
              
                            
              
                                Started the process of internationalization of preparations                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2007                            
              
                        
              
                        
              
                            
              
                                New electronic material assets were injected into A-share listed company HEC (600673.SH)
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2006                            
              
                        
              
                        
              
                            
              
                                Obtained the exclusive authorization of Roche's "Oseltamivir Phosphate"                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2005                            
              
                        
              
                        
              
                            
              
                                HEC  a comprehensive and systematic research institute  was established                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2004                            
              
                        
              
                        
              
                            
              
                                
              Zunyi Base in Guizhou  started construction
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2003                            
              
                        
              
                        
              
                            
              
                                
              ·HEC A-share backdoor listing, stock code: 600673.SH
              ·Dongguan Songshan Lake Factory started construction
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2002                            
              
                        
              
                        
              
                            
              
                                
              ·Guangdong Dongguan Base started construction
              ·Acquired Hubei Changhe Pharmaceutical Co., Ltd. and officially entered the pharmaceutical industry
                                          
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2001                            
              
                        
              
                        
              
                            
              
                                Yichang base in Hubei started construction                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                2000                            
              
                        
              
                        
              
                            
              
                                "Low-voltage and high-volume formed foil" was included in the "Double High and One Excellent" project-oriented plan of the State Economic and Trade Commission's national key technological transformation                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                1999                            
              
                        
              
                        
              
                            
              
                                HEC fully implemented the management of the general outline system, and the first edition of the "Outline of Work" was officially published and released                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                1998                            
              
                        
              
                        
              
                            
              
                                The construction of Shaoguan base in Guangdong began, focusing on the development of electronic materials industry                            
              
                        
              
                    
              
                
              
                                
              
                    
              
                        
              
                            
              
                                1997                            
              
                        
              
                        
              
                            
              
                                Mr. Zhang Zhongneng founded HEC Group